Skip to content

安穆道克斯

US · DOX #1914 按市值排名 上市于 1970
60.06 -0.62 -1.02%
实时 - 追踪5344个代码 - 心跳于334秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

减持
  • 最近一期(2026/Q3)披露持股的机构数量减少了3家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
102.38% -0.09pp
机构数量
554 -3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund88.97%
Hedge Fund6.34%
Public Company3.79%
Private Company2.06%
Individual/Insider1.22%
Government Pension Fund0.89%
Family Office/Trust0.19%

主要股东 截至 2026-06-30

Pzena Investment Management, Inc. 13.39% · 13.99M 股
FMR 8.41% · 8.78M 股
Beutel Goodman & Company Ltd. 4.42% · 4.61M 股
Brandes Investment Partners, LP 4.39% · 4.58M 股
LSV Asset Management 4.32% · 4.51M 股
BlackRock 4.19% · 4.38M 股
Dimensional Fund Advisors 3.92% · 4.10M 股
Federated Hermes, Inc. 3.01% · 3.14M 股
Vanguard Portfolio Management, LLC 2.64% · 2.75M 股
AQR Capital Management 2.52% · 2.63M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪24份申报 · 1次买入 · 8次卖出

姓名职务持股比例
Eli Gelman Director 0.33%
Robert Minicucci Independent Chairperson 0.29%
Tamar Rapaport-Dagim Chief Financial Officer 0.28%
Shimie Hortig Group President of the Americas Business Group 0.17%
Adrian David Gardner Independent Director 0.05%
Ralph De la Vega -- 0.03%
Yvette Gordon-Kanouff Independent Director 0.02%
Tal Rozenfeld GM & Head of Finance 0.02%
Sarah Davis Independent Director 0.02%
Matthew Smith Secretary & Head of Investor Relations 0.00%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-07-27 Tamar Rapaport-Dagim Chief Financial Officer Intent to Sell (Form 144) -12,780 $53.10
2026-07-22 Tamar Rapaport-Dagim Chief Financial Officer Intent to Sell (Form 144) -107,577 $51.22
2026-05-31 Tal Rozenfeld GM & Head of Finance Initial Statement of Beneficial 0 --
2026-05-28 Matthew Smith Secretary & Head of Investor Relations Open Market Disposition -464 $62.51
2026-05-12 Shimie Hortig Group President of the Americas Business Group Other Acquisition +84,483 --
2026-03-30 Shimie Hortig Group President of the Americas Business Group Initial Statement of Beneficial 0 --
2026-03-17 Robert Minicucci Independent Chairperson Initial Statement of Beneficial 0 --
2026-03-17 John MacDonald Independent Director Initial Statement of Beneficial 0 --
2026-03-17 Adrian David Gardner Independent Director Initial Statement of Beneficial 0 --
2026-03-17 Véronique Morali Director Initial Statement of Beneficial 0 --
2026-03-17 Eli Gelman Director Initial Statement of Beneficial 0 --
2026-03-17 Tamar Rapaport-Dagim Chief Financial Officer Initial Statement of Beneficial 0 --
2026-03-17 Ralph De la Vega -- Initial Statement of Beneficial 0 --
2026-03-17 Amos Genish Director Initial Statement of Beneficial 0 --
2026-03-17 Matthew Smith Secretary & Head of Investor Relations Initial Statement of Beneficial 0 --
2026-03-17 Sarah Davis Independent Director Initial Statement of Beneficial 0 --
2026-03-17 Yvette Gordon-Kanouff Independent Director Initial Statement of Beneficial 0 --
2026-03-17 Rajat Raheja Division President of Amdocs Development Centre India LLP Initial Statement of Beneficial 0 --
2025-09-01 Rajat Raheja Division President of Amdocs Development Centre India LLP Intent to Sell (Form 144) -2,285 $85.50
2025-02-27 Matthew Smith Secretary & Head of Investor Relations Intent to Sell (Form 144) -525 $87.74

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:15 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

安穆道克斯 讨论区 0 条评论

发表评论